Literature DB >> 19641701

Effects of metoprolol and amiodarone combination on heart rate, myocardial contractility and coronary flow: Study in isolated perfused rat hearts.

Wagner C Pádua-Filho1, David P Brasil, Hueverson J Neves, Otoni M Gomes, Edimar A Bocchi.   

Abstract

BACKGROUND: Beta-blockers and amiodarone have been used concomitantly to treat arrhythmias associated with congestive heart failure. However, the combination of metoprolol and amiodarone has only been studied restrospectively, and its potential effects in congestive heart failure remain to be properly elucidated in prospective trials.
OBJECTIVE: The present investigation focused on evaluating the pharmacological interaction between metoprolol and amiodarone in an isolated perfused rat heart preparation.
MATERIALS AND METHODS: Adult male Wistar rats (n=24) were divided into four groups of six animals, and the effects of the metoprolol/amiodarone combination on systolic pressure, myocardial contractility (dP/dt), coronary flow (CF) and heart rate were analyzed, and the interdependent variables were compared.
RESULTS: There was a negative chronotropic effect by both metoprolol and the metoprolol/amiodarone combination in isolated rat hearts. However, the acute effects of the metoprolol/amiodarone combination showed no myocardial contractility depression or bradycardia accentuation compared with metoprolol alone. CF increased by 9.2% at minute 1 through minute 5 (P=0.004) with the metoprolol/amiodarone combination. There was no difference in systolic pressure or myocardial contractility among the groups.
CONCLUSIONS: The acute effects of the metoprolol/amiodarone combination in the isolated rat heart were an increase in CF, and no myocardial contractility depression or bradycardia accentuation.

Entities:  

Keywords:  Amiodarone; Coronary flow; Heart rate; Langendorff technique; Metoprolol; Myocardial contractility

Year:  2004        PMID: 19641701      PMCID: PMC2716268     

Source DB:  PubMed          Journal:  Exp Clin Cardiol        ISSN: 1205-6626


  26 in total

1.  Preservation of membrane phospholipids by propranolol, pindolol, and metoprolol: a novel mechanism of action of beta-blockers.

Authors:  X K Liu; R M Engelman; H R Agrawal; D K Das
Journal:  J Mol Cell Cardiol       Date:  1991-10       Impact factor: 5.000

2.  Metoprolol reduces reperfusion-induced fibrillation in the isolated rat heart: protection is secondary to bradycardia.

Authors:  A Tosaki; L Szekeres; D J Hearse
Journal:  J Cardiovasc Pharmacol       Date:  1987-11       Impact factor: 3.105

3.  Efficacy and safety of low doses of beta-blocker agents combined with amiodarone in refractory ventricular tachycardia.

Authors:  J Tonet; R Frank; G Fontaine; Y Grosgogeat
Journal:  Pacing Clin Electrophysiol       Date:  1988-11       Impact factor: 1.976

4.  Effects of atenolol and some other beta-adrenoceptor blocking agents on norepinephrine-induced responses in isolated and perfused rat hearts.

Authors:  J Nakasone; T Kato; K Noguchi; F Nagamine; M Sakanashi
Journal:  Jpn J Pharmacol       Date:  1988-08

5.  Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)

Authors:  H C Doval; D R Nul; H O Grancelli; S V Perrone; G R Bortman; R Curiel
Journal:  Lancet       Date:  1994-08-20       Impact factor: 79.321

6.  Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.

Authors:  S N Singh; R D Fletcher; S G Fisher; B N Singh; H D Lewis; P C Deedwania; B M Massie; C Colling; D Lazzeri
Journal:  N Engl J Med       Date:  1995-07-13       Impact factor: 91.245

7.  A prospective study of the efficacy and safety of adjuvant metoprolol and xamoterol in combination with amiodarone for resistant ventricular tachycardia associated with impaired left ventricular function.

Authors:  Y Bashir; V E Paul; M J Griffith; J F Sneddon; T G Farrell; D E Ward; A J Camm
Journal:  Am Heart J       Date:  1992-11       Impact factor: 4.749

8.  Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group.

Authors:  F Waagstein; M R Bristow; K Swedberg; F Camerini; M B Fowler; M A Silver; E M Gilbert; M R Johnson; F G Goss; A Hjalmarson
Journal:  Lancet       Date:  1993-12-11       Impact factor: 79.321

9.  Acute amiodarone terminates ventricular fibrillation by modifying cellular Ca++ homeostasis in isolated perfused rat hearts.

Authors:  S Kojima; S T Wu; J Wikman-Coffelt; W W Parmley
Journal:  J Pharmacol Exp Ther       Date:  1995-10       Impact factor: 4.030

10.  Acute effects of amiodarone on ultrastructure and electrical activity of isolated guinea pig hearts.

Authors:  G Stark; M Windisch; E M Haller; U Stark; T Pieber; E Pilger; G J Krejs; H A Tritthart
Journal:  Cardiovasc Res       Date:  1991-10       Impact factor: 10.787

View more
  3 in total

1.  Ivabradine reduces heart rate while preserving metabolic fluxes and energy status of healthy normoxic working hearts.

Authors:  Benjamin Lauzier; Fanny Vaillant; Roselle Gélinas; Bertrand Bouchard; Roger Brownsey; Eric Thorin; Jean-Claude Tardif; Christine Des Rosiers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-01-21       Impact factor: 4.733

2.  Post-Operative Atrial Fibrillation: Current Treatments and Etiologies for a Persistent Surgical Complication.

Authors:  Leilani A Lopes; Devendra K Agrawal
Journal:  J Surg Res (Houst)       Date:  2022-03-28

3.  Exploratory studies of some Mexican medicinal plants: Cardiovascular effects in rats with and without hypertension.

Authors:  Gil Alfonso Magos-Guerrero; Jacinto Santiago-Mejía; Omar F Carrasco
Journal:  J Intercult Ethnopharmacol       Date:  2017-07-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.